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INTRODUCTION
Improved  healthcare  services  and  socio  economic  growth  has  lead  to 
increase in the life expectancy at birth and the number of elderly persons in our country. 
This has posed a new challenge to the health needs and care of elderly men and women.
The  menopause  is  that  point  in  time  when  permanent  cessation  of 
menstruation occurs following the loss of ovarian activity. The years prior to menopause 
that  encompass  the  change  from normal  ovulatory  cycles  to  cessation  of  menses  are 
known  as  the  perimenopausal  transitional  years,  which  is  marked  by  irregularity  of 
menstrual cycles.
Epidemiological studies have shown that during this phase women are at 
increased  risk  for  arterial  diseases,  prone to  urogenital  problems  and osteoporosis.  Of 
these,  osteoporosis  is  the  most  common  consequence  of  menopause  and  currently  is 
considered a major public health concern. Osteoporosis and its associated risk of fractures 
are preventable if diagnosed in time. Half of all the post menopausal women will have an 
osteoporosis related fracture during their lives including one quarter who will develop a 
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vertebral  deformity  and 15% who will  suffer  a  hip fracture.  As  early  as  1975 it  was 
acknowledged that bone density measurements were related to future fracture risk. In the 
1990’s, the magnitude of this risk in relation to the age and bone density was carefully 
measured in several well designed longitudnal studies.
Several techniques exists for measuring bone mass or density. Quantitative 
Ultrasound (QUS) is a newer evolving promising technique which is finding increasing 
application.  Retrospective  and  prospective  studies  have  shown  that  QUS  may  be  an 
alternative  or  complementary  investigation  to  Dual  Energy  X-Ray  Absorptiometry 
(DXA). QUS has been used in this study as a screening tool as it is inexpensive relatively 
portable and free of ionizing radiation 
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AIM OF THE STUDY
1 To  assess  the  level  of  osteoporosis  in  perimenopausal  and  menopausal 
women
2 To screen  the post-menopausal  women  having  either  natural  or  surgical 
menopause who are at high risk to have fractures.
3 To analyze the role of risk factor in identifying high risk women
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REVIEW OF LITRATURE
Osteoporosis  has  been  defined  as  “A  Systemic  skeletal  disease 
characterized  by  low bone  mass  and  micro  architectural  deterioration  of  bone  tissue, 
leading to enhanced bone fragility and a consequent increase in fracture risk”  
It is characterized by generalized reduction in bone mass due to subnormal 
osteoid  production,  excessive  rate  of  de-ossification  and  sub  normal  osteoid 
mineralization. It  has also been defined as bone mineral  density that  is below the age 
adjusted  reference  range,  or  more  than  one  standard  deviation  below the  mean  for  a 
particular age.
On the basis of the modified classification by NORDIN (1964) which takes 
account of findings by the World Health Organization (WHO) on causes of generalized 
and secondary osteoporosis, osteoporosis can be generalized or localized.
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GENERALISED OSTEOPOROSIS
PRIMARY:  On  the  basis  of  patterns  of  bone  loss  and  fracture  RIGGS  and 
MELTON  (1988)  identified  two  types  of  primary  osteoporosis.  Type  I  primary 
osteoporosis is post-menopausal or osteoclast mediated and type II primary osteoporosis is 
senile or osteoblast mediated.
Type  I  primary  osteoporosis  is  charecterised  by rapid  bone loss  seen in 
recent post-menopausal women. The turnover of trabacular bone is accelerated. Therefore, 
distal radial and vertebral fractures are common.
Type  II  osteoporosis  is  characterized  by  age  related  bone  loss,  calcium 
deficiency or hyperparathyroidism. Primary generalized osteoporosis is the subject of this 
study.
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EPIDEMIOLOGY
Osteoporosis is a global problem occurring in every geographic area and 
affecting 150 million men and women worldwide. Our knowledge of magnitude of the 
problem is very limited and most of the available data is from industrialized nations. In the 
USA,  10  million  individuals  have  osteoporosis  and  18  million  have  osteopenia. 
Osteoporosis  affects  30%  of  post  menopausal  White  women  in  the  USA  and  the 
proportion rises  to  70% in women over  the  age of  80 years.  Globally osteoporosis  is 
highest in Whites and Asians and lowest among Blacks.
According to the World Bank report,  the world wide population of post 
menopausal women which was 470 million in 1990 is expected to increase to 1.2 billion 
by the year 2030 and 76% of these women would be living in developing countries. In 
India it is projected that by the year 2030 the population of the post menopausal women 
will be the second highest in the world, second to that in China. The WHO Technical 
Report Series 843-Assesment of Fracture Risk and its Application to screening for post 
menopausal osteoporosis, predicts a significant increase in fracture neck of femur among 
the Asian population over a period of time. The incidence of fracture of the hip is likely to 
rise across the world from 840,000 in 1986 to approximately 6.26 million in 2050 and 
71% of these fracture are likely to occur in the developing world. Indian women are likely 
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to have a fracture incidence of neck of femur, of approximately 1.2 million per year. Thus 
the burden, of osteoporosis in the Indian scenario will be immense
THE INDIAN SCENARIO
Osteoporosis is highly prevalent in India. An estimated 61 million people in 
India are reported to be affected by it. Recent data indicate that Indians have lower bone 
density  than  their  North  American  and  European  counterparts.  It  is  reported  that 
osteoporotic fractures occur 10 to 20 years early in Indians as compared to Caucasians and 
that bone mineral  density (BMD) in Indian population were approximately 15% lower 
than those in Caucasian women.
THE BURDEN OF OSTEOPOROSIS
ECONOMIC:  The National  Osteoporosis  Foundation in  the USA estimates  the 
cost  related  hospitalization,  out  patient  care,  long  term  care,  and  disability  due  to 
osteoporotic morbidity to be more than 60 billion dollars annually. In 1995, osteoporotic 
fractures were the cause of 432,000 hospital admissions in the US. Heath care expenditure 
attributable to osteoporotic fracture in the USA in the year 1995 was estimated to be US 
dollars 13.8 billion. The total number of deaths related to hip fracture disease ranges from 
20,000 to 30,000 annually. 
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SOCIAL: Fracture related to osteoporosis are common. Every second woman 
and every third man over the age of 50 will eventually suffer from an osteoporosis related 
fracture.  The lifetime risk for  an osteoporotic fracture of  hip,  spine or wrist  has  been 
reported to be 40%. The risk for hip fracture is between 11 and 18 percent in women, 
which is equal to the combined risk for breast cancer and ovarian cancer, and exceeds her 
risk of developing endometrial or breast cancer.
PATHOPHYSIOLOGY
The basic unit  of  bone is  the Haversian system which is  also known as 
Osteon, the center of which is filled with osteoblasts and osteoclasts. Osteoblasts are the 
prime cells responsible for major production and synthesis of protein and mineralisation of 
bone. Osteoclasts are primarily responsible for bone resorption.
There are three aspects  of physiology that  comes into prominence when 
osteoporosis is discussed
• Re-Modeling
• Influence of Hormones on Bone
• Influence of Nutrition on Bone
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Bone remodeling is regulated by systemic hormones and by growth factor 
which include Transforming Growth Factor alpha and beta, insulin like growth factor, 
platelet derived growth factor, interleukins, cytokines and prostaglandins 
RE-MODELING: Modeling  and re-modeling  change  the structure  and shape of  the 
bone continuously. Modeling takes places during fetal life and goes on till  the second 
decade.  Bone is  formed in  location  in  such  a  way as  to  change the shape and micro 
architecture of the skeleton
Bone  re-modeling  occurs  throughout  adult  life.  This  includes  bone 
formation and resorption and since it occurs at the same anatomical location, there is no 
significant structural change in the shape of the bone. The bio mechanical integrity and 
strength of the skeleton is as a result of re-modeling. Approximately 5 to 10 % of bone is 
replaced every year by re-modeling. The morphological dynamic structure of turnover is 
the BASIC MULTICELLUAR UNIT (BMU). 
The  re-modeling  process  is  initiated  by  osteoclastic  activity  and  is 
controlled by various hormones and locally produced cytokines. 
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INFLUENCE OF HORMONES ON BONE: A  number  of  hormones  play  a 
significant role in bone metabolism and include estrogens, progesterone, growth hormone, 
testosterone, cortisone, thyroid hormone, calcitonin and insulin.
Estrogens play an important role in maintenance of bone strength. When 
estrogen levels are declined bone remodeling increase. Each remodeling unit is initiated 
by  osteoclastic  excavation  followed  by  osteoblastic  refilling.  Estrogen  exerts  tonic 
suppression of remodeling and maintains a balance between osteoclastic and osteoblastic 
activity. In the absence of estrogen, osteoclastic activity predominates resulting in bone 
resorption.
The precise mechanism of action for sex steroid protection of bones remains 
unknown. However, a growing body of knowledge indicates complex interactions at the 
molecular  level  with  both  a  classical  pathway  involving  genomic  transcription  by 
hormone  receptors  and  a  non-genomic  pathway  that  inhibits  apoptosis.  Increased 
efficiency  of  calcium  absorption  secondary  to  estrogen  induced  enhancement  of  the 
availability of vitamin D and a direct role for the estrogen receptors in the osteoblasts are 
important factors.
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Many  estrogen  dependent  growth  factors  and  cytokines  are  involved  in 
bone re-modeling. Estrogen modulates the production of bone resorbing cytokines such as 
interleukin 1 & 6, bone stimulating factors such as insulin like growth factors 1 & 2, 
colony stimulating factor, osteoprotegerin and transforming growth factor beta. Estrogen 
increases vitamin D receptors in osteoblasts and this may be a method by which estrogen 
modulates vitamin D activity in bone. There is little evidence that estrogen affects bone by 
altering the circulating calcitropic hormones. Thus the actions of estrogens are primarily 
direct  effects  on bone and important  effects  on vitamin  D metabolism,  and renal  and 
intestinal handling of calcium.
The  importance  of  loss  of  ovarian  function  in  the  evaluation  of  post 
menopausal osteoporosis was first emphasized by Albright and Collaborators in 1940.
INFLUENCE OF NUTRITION ON BONE:
Vitamin D: Role  of  vitamin  D  is  increasingly  being  regarded  as  that  of  a 
calcitropic hormone. This is considered as a major steroid hormone that plays a vital role 
in calcium metabolism.
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Calcium: Calcium alters the bone related hormones and local hormones and 
alters physical chemical properties of the bone mineral. The major mechanism whereby 
calcium affects the bone is probably through inhibition of Parathyroid hormone secretion.
Calories: Osteoporotic patients frequently have low intake of all nutrients.
Vitamin K: Vitamin  K  prevents  carboxylation  of  GLA  proteins,  including 
osteocalcin.
Vitamin A: Vitamin  A has been shown to increase bone resorption,  and high 
levels are associated with osteoporosis. Excess in dietary intake of vitamin A is associated 
with reduced bone mineral density and increased risk of hip fracture.
RATE OF BONE LOSS
Evidence has shown that the bone mass peaks in the second decade of life, 
although  heredity and environmental factors may influence this timing. Peak bone mass is 
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approximately  20% greater  in  men  than  women  and  is  greater  in  black  than  whites. 
Gradual lose of skeletal mass begins to occur in the fifth or sixth decade of life in man and 
in both the decade in women. After the age of about 50 years, bone is lost at a rate of 
0.75% to 1% per year which increases to a rate of 2% to 3% after menopause.
CLINICAL MANIFESTATION OF OSTEOPOROSIS
These include acute or chronic back pain,  loss of height with change in 
body stature, fracture after minimal trauma, restricted movement, immobility, dependence 
on nursing, loneliness, depression, reduced quality of life and increased mortality.
DENSITOMETRY
The term ‘peak bone mass’ is defined as the amount of bone that is present 
at the end of skeletal maturation and determines in a major way, the onset of osteoporosis 
in later life. This peak bone mass occurs between 30 and 35 years of life, both in the male 
and female, but there is rapid decline in the bone mass in the post-menopausal female. A 
fracture risk is present particularly in osteoporosis since the bone mass that is present in 
any point of life during adult life is the variation between the amount accumulated at the 
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time of peak bone mass and the loss with ageing. Hence, the increase in bone mass is an 
important factor to prevent osteoporosis at a later date.
BONE MINERAL DENSITY
Bone mass is directly dependent both on volume/size and the density of the 
mineralized tissue and contained within the periosteal  envelope. Bone Mineral  Density 
(BMD) is a summation of several structural components which may evolve differently in 
response  to  genetic  and  environmental  factors  but  bone  mineral  density  is  directly 
proportional to bone strength and would indicate the extent to which a fracture can occur 
at various sites in the human body
Bone mineral density measurement has a significant relation to fracture risk, 
The first prospective study to evaluate the association between bone density and fractures 
were published in 1975. Ross Et Al in a four year study of bone mass at the calcaneus 
showed an odds ratio of 5.0 for fracture of the spine. 
Cummings Et Al in a study of 8134 post menopausal women showed odds 
ratio of 2.0 for the fracture of the hip using bone mass of the calcaneus.
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The odds ratio for the fracture of the wrist was 1.8 in a study by Black et al.
DIAGNOSING OSTEOPOROSIS
The relation between bone mineral  density and fracture risk in untreated 
patients  has  been  evaluated  prospectively  in  several  studies.  A  decrease  in  BMD  is 
associated with increased risk of fracture. The predictive power of BMD for hip fracture is 
similar to the predictive power of blood pressure for stroke and better than the predictive 
power of serum cholesterol level for cardio-vascular disease. In post menopausal women 
the  risk  for  hip  fracture  increases  by  a  factor  of  2.6  per  each  age  adjusted  standard 
deviation decline in BMD of femoral neck. The BMD at other sites (radius, calcaneus, hip 
and spine) has also been shown to co-relate with fracture risk at all sites.
Defining the risk for osteporotic fractures in only the first step in the final 
diagnosis  of  osteoporosis.  Changes  in  BMD  are  observed  with  aging,  in  addition  to 
differences in BMD between the sexes and ethnic groups. BMD results must be compared 
with those of age, sex, and race-matched controls. The use of T and Z score has become 
an important  part  of the interpretation of  BMD measurements.  The Z score  gives the 
patient’s result as the deviation from the mean of age-matched controls divided by the 
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standard deviation of this mean and is an indication of biologic variability. The T score is 
associated with the peak bone mass of young normal adults and calculated similarly to the 
Z score. The WHO has advocated the use of diagnostic thresholds based on a comparison 
with young normal person for the diagnosis of osteoporosis.
 Table : WHO Criteria for Defining Osteoporosis
Condition Description
Normal BMD value with  1 SD of  the  young 
adult reference mean (T ≥ -1.0)
Osteopenia BMD value of more than 1 SD below 
the young adult mean but less than 2.5 
SD below this value ( -1.0 > T > -2.5)
Osteoporosis BMD value of 2.5 SD or more below 
the adult mean value (T ≤ -2.5)
Established Osteoporosis BMD value of 2.5 SD or more below 
the adult mean value (T ≤ -2.5) in the 
presence  of  one  or  more  fragility 
fractures
INDICATIONS FOR BONE MINERAL DENSITY MEASUREMENT
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Deciding  which  patients  to  consider  for  BMD  measurements  usually 
involves weighing various risk factors on individual basis. 
RISK FACTORS
The risk factors for osteoporosis are enumerated below
A. Natural Progression 
1. Increasing age 
2. Female 
B. Constitutional 
1. White (fair-skinned) or Asian origin 
a. Black and Hispanic patients have lower rates 
2. Family History Maternal Hip Fracture 
3. Low body weight or small stature 
a. Weight below 58 kilograms 
b. Body Mass Index (BMI) <25
C. Family History 
1. Osteoporosis 
2. Kyphosis 
3. Pathologic fracture 
D. Lack of Bone loading or Exercise 
1. Sedentary 
E. Early Hypogonadism 
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1. Premature Ovarian Failure (e.g. Female Athlete Triad) 
2. Orchiectomy for Prostate Cancer in men 
F. Inadequate Calcium Intake or absorption 
1. Low calcium intake 
2. Smoking (female RR 2.0, male RR 5.0) 
3. Excessive alcohol 
4. High Caffeine intake 
G. No longer considered a risk factor 
1. High phosphate (soda) does not cause Osteoporosis 
National Institute of Health recommends using the individualized approach 
in  deciding  which  patients  should  have  BMD  testing.  The  National  Osteoporosis 
Foundation has recommended specific guidelines for selective screening. 
BONE MASS ASSESSMENT
24
Bone densitometry is the single best predictor of osteoporotic fracture risk.
Both peripheral  and central  bone sites  can be measured to assess  BMD. 
Because  osteoporosis  is  a  systemic  disease,  the  risk  of  spine  or  hip  fracture  can  be 
estimated from measurements obtained at peripheral measurement sites. However, bone 
mass may be discordant  at  various skeletal  site  within an individual  patient.  Thus the 
skeletal area of most interest for fracture risk is a most accurate measurement site.
TECHNIQUES FOR MEASURING THE BONE MASS OR DENSITY
IONIZING
CONVENTIONAL SKELETAL RADIOGRAPHY: Conventional  X-ray  is 
relatively insensitive and bone lass is apparent only when bone mass has decreased by 
about 30 to 50 %.
RADIOGRAPHIC  PHOTO  DENSITOMETRY:  The  technique  depends  on 
measuring the optical density of X-Ray films of the bones. The radiation dose is the same 
as for radiogrammetry 
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RADIOGRAMMETRY: It  relies  on linear  measurements  in  X-Ray films  on 
cortical  bone taken under  standarised  conditions.  It  is  less  sensitive  and specific  than 
absorptiometric measurements.
SINGLE ENERGY X-RAY ABSORPTIOMETRY: It most commonly uses a 
gamma-ray source coupled with a scintillation detector, which together scan across the 
area of interest.
The technique has been used in the peripheral skeletal. The radiation dose is 
< 1 µSv
DUAL ENERGY ABSORPTIOMETRY: It is based on the method of X-
ray spectro-photometry.  The principle behind DEXA is  that  different  tissues attenuate 
radiation  of  distinct  energies  to  different  extents.  Measurements  can  be made  at  both 
peripheral and central skeletal. DEXA has high short term and long term precision.
Table: Different bone densitometry techniques
Technique
Regions of 
interest
Units reported
Precision 
(%CV)
Radiation 
exposure 
(μSv)
DXA Spine, hip, total BMD (g/cm2) 1%-2% 1-10
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body
pDXA Radius, calcaneus BMD (g/cm2) 1%-2% 0.1
QCT Spine BMD (g/cm3) 3% 50-500
pQCT Radius, Tibia BMD (g/cm3) 1%-2% 1-3
RA Phalanx BMD (g/cm2) 1%-2% 10
QUS Calcaneus, tibia, 
multisite
BUA (dB/MHz)
SOS (m/s)
0.1% - 5% None
MRI Peripheral, 
multisite
app. BV/TV (%)
app. Tb.Th (mm)
app. Tb.N (mm-1)
app. Tb.Sp (mm)
2%-9% None
QUANTITATIVE COMPUTED TOMOGRAPHY (QCT): In  QCT  a  thin 
transverse slice through the body is imaged which gives a measure of volumetric bone 
mineral density. Cancellous bone can be measured independently of surrounding cortical 
bone.  The  advantage  of  the  technique  is  that  the  cancellous  bone  can  be  examined 
separately from cortical bone.
NEUTRON ACTIVATION ANALYSIS (NAA):  The application of NAA to bone 
mineral  measurement  relies  on the fact  that  99% of  the  calcium in  the  body is  in  the 
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skeleton.  When  the  area  under  examination  is  irradiated  with  neutrons  many  of  its 
constituent  elements  become  radio-active  and  can  be  identified  and  quantified  by 
examining the characteristic gamma-ray emission. 
QUANTITATIVE ULTRASOUND
It is due to the increasing awareness of the impact of osteoporosis causing 
morbidity and mortality,  due to its  complications to the patient and in addition to the 
financial burden on the patient or the public health system that there is growing interest in 
the technique for early diagnosis of the disease process. Although DEXA which provide 
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BMD is an accepted standard it explains only about 70% – 75% change in the strength of 
the  bone.  It  does  not  take  into  account  the  remodeling  of  bone,  ineffective  bone 
architecture or the quality of the bone, bone micro-architectural distortion due to fatigue or 
stress and measurement artifacts due to overlying high density substance.
QUS is a newer evolving promising technique which is finding increasing 
application. Calcaneum is the most common logical anatomical site for assessing bone 
mass by QUS. The other sites are proximal phalanges metacarpals radius, etc.
TECHNIQUE
The conventional ultrasound works on pulse-echo technique. They produce 
a reflective image. The QUS system produces a transmission image with the help of two 
transducers used for the purpose of bone characterization range for 0.1 to 1 MHz. The 
parameters  which  are  conventionally  assessed  are  Broadband  Ultrasound  Attenuation 
(BUA) and Speed of Sound (SOS). The BUA values are directly affected by the bone 
mass of the assessed calcaneum whereas SOS represents the internal architecture of the 
trabaculae and or the elasticity of the bone.
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The stiffness Index relates to bone density, structure and elasticity of the 
bone and provides a clinically significant score with a high diagnostic sensitivity. The 
stiffness index for a patient is direct indicator of the fracture risk of the patient.
The scientific evidence permits  conclusions comparing the ability of US 
(which measures the “Stiffness index” of bone) to DXA (which measures bone density) to 
predict fracture risk. The evidence consists of 3 prospective cohort studies, and a number 
of  cross-sectional  and/or  retrospective  studies.  The  two  studies  that  are  strongest 
methodologically  each  followed  several  thousand  patients  prospectively  over  a  2-year 
period and directly compared the predictive ability of US of the heel with DXA. Both 
studies were consistent in reporting that US of the heel was roughly equivalent to DXA in 
predicting overall fracture risk. DXA of the hip was somewhat more predictive for hip 
fractures  than  US  of  the  heel,  but  the  confidence  intervals  for  these  relative  risks 
overlapped widely.
Table : Sensitivity and specificity at various T score cut-offs
T Score
DEXA femoral neck Heel stiffness Index
Sensitivity Specificity Sensitivity Specificity
-3.5 25 97 71 66
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-2.5 62 80 98 28
-2 79 68 99 20
-1 99 25 100 7
Optimal cut-
off -2.2 -3.4
76 74 75 63
The calcaneus is the most popular measurement site for several  reasons: 
Calcaneus  consists  of almost  only metabolically active trabecular  bone and may early 
express skeletal changes, is weight-bearing bone like the neck of femur and the vertebral 
bodies and is easily accessible.
Ultrasound  is  a  traveling  mechanical  vibration  and  the  mechanical 
properties of the medium progressively alter the shape, intensity (energy per second per 
unit area) and speed of the propagation wave. Therefore, the nature of the method being 
able to provide some qualitative bone features in addition to bone quantity seems to be 
especially promising. 
QUALITY OF BONE ASSESSED BY QUS
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A potential of QUS to express qualitative features of bone seems to be one 
of the most important advantages of the method.
Bone disease may affect both bone quality and quantity. It is well known 
that  BMD is  important  but  no sole  determinant  of  bio-chemical  property of  skeleton. 
Fundamental  rules  of  bio-mechanics  indicate  that  the  strength  depends  not  only  on 
material  quantity  but  also on its  internal  structure size  and bio-chemical  properties.  It 
should be known that the risk of bone fracture depends on its density, internal structure 
(mainly trabacular, anisotropy, connectivity and porosity) and bio-mechanical properties.
In contrary to DEXA method QUS expresses anisotropic properties of bone 
and internal structure of trabaculae. Such data indicate that QUS may give some additional 
data to those given by densitometry evaluation of bone independent of the BMD.
QUS  may  provide  some  additional  data  on  fracture  risk  because  QUS 
parameters  express  both bone mass  and bone quality.  QUS measures  two parameters: 
speed of sound (SOS) and broadband ultrasound attenuation (BUA). SOS is believed to 
express elasticity and bone mass and higher SOS values are obtained in denser and more 
elastic bone tissue. BUA is a function of absorption and dispersal of ultrasound wave, and 
is associated with density and structure of trabecular bone. Some researchers consider that 
common  use  of  QUS  and  BMD  measurements  may  better  express  biomechanical 
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competence  of  bone  than  BMD  measurements  alone,  and  others  stated  that  QUS 
parameters  are  able  to  predict  mechanical  properties  of  bone  independently  of  bone 
density. It could be concluded that a potential of QUS to express some qualitative features 
of bones cannot be neglected. This ability of the method is the most promising area of 
future studies and a combination of data on qualitative bone features and bone quantity 
would lead to wider clinical applications in the future. 
TREATMENT OF OSTEOPOROSIS
HORMONE REPLACEMENT THERAPY: Estrogen  preserves 
positive  calcium  balance  by  suppressing  the  bone  remodeling  rate.  It  decreases  the 
activation of new remodeling units and thereby suppresses parathyroid hormone mediated 
bone resorption. The incidence of osteoporotic fractures is 2-3 times greater in women 
than men  because the peak  bone mass  is  lower  and there  is  an  accelerated  loss  after 
menopause (Melton et al 1992). Progestogens should be administered along with estrogen 
therapy  for  all  women  who  have  intact  uterus.  Continuous  combined  estrogen  and 
progestogen avoids monthly withdrawal bleeding to a considerable extent.
The  clinical  effects  of  HRT  on  preservation  of  bone  mineral  density 
hasbeen proved beyond doubt. However, individualization of treatment, close monitoring 
and total health care is essential to exert a long term benefit. HRT can be started in the 
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perimenopausal period to treat climacteric and urogenital symptoms and continued for a 
long  time  for  prevention  of  osteoporosis  and  cardiovascular  disease.  However,  for 
effective prevention, 5 to 10 years is the period recommended.
Several clinical trials have demonstrated the reduction of fracture risk and it 
is shown that duration of therapy should be as long as possible because the bone mass 
starts falling again when HRT is stopped. The contraindication for estrogens are history of 
breast cancer or endometrial cancer,  severe liver dysfunction and porphyria. In women 
with  fibroids,  endometriosis,  migraine,  venous  thrombosis  and  familial 
hypertriglycerdaemia, gallstones, epilepsy and those with increased risk of breast cancer, 
the clinicians need to be cautious and consider alternative therapies or monitor them very 
closely.
Felson et al (1993) investigated the effects of 10 years of HRT on BMD in 
postmenopausal  women.  After  10  years  of  therapy,  the  bone  mineral  content  was 
significantly higher in the HRT group when compared to those who received no treatment. 
They noted that women treated for 3 to 4 years had no significant improvement.
Schneider, et al (1997) studied the importance of timing of postmenopausal 
estrogen for  optimal  bone mineral  density.  Estrogen initiated in  the  early  menopausal 
period  and  continued  into  late  life  is  associated  with  the  highest  bone  density. 
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Nevertheless estrogen begun after age of 60 years and continued appears to offer bone-
conserving benefit.
Good  nutrition,  calcium  supplementation,  weight  bearing  exercises  and 
minimising risk factors such as smoking, excessive alcohol and immobilization certainly 
help. In Mumbai, 70% of women in the upper socio-economic and education strata knew 
about HRT but among the lower middle class, only 2-5% of women knew about HRT.
ALTERNATIVE THERAPIES
Calcium  supplements,  bisphosophonates,  calcitriol,  calcitonin,  anabolic 
steroid and sodium fluoride have been tried. Bisphosphonates such as Alendronate have 
been shown to attenuate bone turnover and specifically inhibit osteoclasts mediated bone 
resorption. The increase in BMD is maintained during the treatment and for 12 months 
after  the  treatment.  Liberman  et  al  (1995)  reports  optimal  increase  in  BMD with  10 
mg/day dose and an increase in bone mass of 8.8% at lumbar spine and 5.9% at femoral 
neck after 3 years of therapy. Addition of Alendronate to ongoing HRT resulted in 5 times 
greater increase in bone mineral density than HRT alone, in postmenopausal women with 
low BMD.
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Calictriol deficiency is believed to be significant factor in postmenopausal 
osteoporosis and its presence is an important regulator of intestinal calcium absorption. 
Anabolic steroids can be used only for short  periods in extreme cases of debility and 
osteoporosis.  Calcium  supplements  are  useful  when  used  along  with  estrogens  in 
sufficient  doses  –  1000  to  1500  mg.  Vitamin  D3  is  needed  for  intestinal  calcium 
absorption. With increased age, the kidney produces less 1,25-dihydroxy vitamin D 9th 
active  form)  from  Vitamin  D.  Raloxifen  is  a  selective  estrogen  receptor  modulator 
(SERM) and has a favorable effect on bone and lipids and does not stimulate endometrium 
or breast. Alpha D3 is used to regulate mineral metabolism by increasing calcium and 
phosphate absorption from the intestinal tract as well as by mobilizing these minerals from 
the bones.
These alternatives therapies have to be specially considered for women who 
do not wish to take HRT or when HRT is contra-indicated.
36
MATERIALS AND METHODS
The present study has been conducted taking 98 perimenopausal and 112 
postmenopausal women in age group from 40 and above between the period of Jan’04 to 
Aug ’05. 
The study was conducted at Kilpauk Medical College, Kilpauk , Chennai
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STUDY DESIGN 
Randomized prospective study
INCLUSION CRITERIA
Perimenopausal women age ≥ 40 yrs
Post menopausal women who had experienced surgical/natural menopause 
irrespective of age
EXCLUSION CRITERIA
1. Women with preexisting atraumatic fracture 
2. Patients with secondary osteoporosis
3. Women with chronic illness
4. Women with current use of thyroid hormones or any other drug that might affect bone 
mass like diuretics, anticonvulsants, barbiturates.
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The  BMD  was  assessed  using  Lunar  Achilles  Utrasound  Densitometer 
software version 1.3 in os calcis of right foot. The BMD was assessed as stiffness using 
SOS  (speed  of  sound)  and  BUA  values  (Broad  Band  Ultrasound  Attenuation).The 
ultrasound method uses the principle of sound attenuation to plot mineral density. It is 
non-invasive, less expensive and painless procedure. 
The results of BMD were analysed when expressed in standard deviation 
units  in  comparison  to  the  young  normals  and  are  known  as  “T-scores”.
Calculation formula: 
T-score = Patients BMD – Reference BMD
                  Reference SD
The % Young adult  value (T-score)  compares  a patient’s  stiffness  value 
with expected value for 20 years old subject  of same sex and nationality. The risk of 
fracture doubles for each 1 SD decrease of bone mineral density.
The %age matched value (or Z-score) compares the patient’s stiffness value 
with expected stiffness value for reference group of same age and sex. The bone mineral 
density declines along the normal regression line with advancing age. The bone mineral 
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density of the female is assessed when compared with young normal adults of same sex 
and nationality. i.e. T-score”.
A detailed history specially  related to  menopausal  problems  and general 
medical  problems  was  noted.  High  risk  factors  such  as  surgical  menopause  with 
oopherectomy, history of treatment with glucocorticoid etc. were noted. 
Patients  answered  a  questionnaire  inquiring  about  their  age,  physical 
activity over the last 5 years, and knowledge of family history of osteoporosis. Physical 
activity was analyzed as “positive”,
i.e., regularly practiced throughout the year (at least twice a week), or “negative”, i.e., all 
other situations. The following activities were considered to be sports: walking, cycling, 
and swimming. A complete dietary inquiry was obtained, and the energy, caffeine and 
calcium intakes were calculated. Patients were weighed and height measured and BMI 
was reported as kg/m2.
For comparison, patients were grouped according to Z score and T score. 
Those with a Z score below -1 (group 1) were compared to those with a Z score equal to 
or greater  than -1 (group 2).  The effect  of the different variables  on the Z score was 
studied by stepwise multivariate regression analysis. 
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And those with the T score below -1 (Normal) were compared with the T 
score equal to or grater than -1 and less than -2.5 (Osteopenia) and T score equal to or 
grater than -2.5 (Osteoporosis)
Results were analysed using NCSS software.
OBSERVATION AND ANALYSIS
Table 1
AGE DISTRIBUTION
Age in Years Normal Osteopenia
Osteoporosi
s
Total
41-45 61 2 1 64
46-50 21 19 2 42
51-55 5 23 8 36
56-60 11 5 12 28
> 60 18 21 1 40
41
Total 116 70 24 210
Table 1 shows the age distribution of the study population. The age ranges from 41 years 
to 75 years.
Mean age for the study group was 52.72 yrs with the standard deviation of 9.59 years
50.6% of the study group were aged between 40-50, 30.4% patients were aged between 
50-60 and 19% of the study group were aged more than 60.
46.6% of the study group were perimenopausal and 53.4% were post-menopausal.
11.42%  of  the  study  population  had  undergone  Hysterectomy  with  removal  of  both 
ovaries
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Table 2
PERCENTAGE DISTRIBUTION OF BMD IN VARIOUS AGE 
GROUPS
Age 
Normal
T ≥ -1.0
Osteopenia
-1.0 > T Score > 
-2.5
Osteoporosis
T ≤ -2.5
41-45 95 3 2
46-50 50 45 5
51-55 14 64 22
56-60 39 18 43
> 60 45 52 3
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Table 3
DEMOGRAPHY
Place of Living Perimenopausal Menopausal Total
Urban 80 90 170
Rural 18 22 40
Total 98 112 210
81% of the study population were from the urban area and the 19% from the rural area.
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Table 4
DISTRIBUTION IN URBAN/RURAL AREA
Place of Living Normal Osteopenia Osteoporosis Total
Urban 102 50 18 170
Rural 14 20 6 40
Total 116 70 24 210
29% of urban population were osteopenic and 10% were osteoporotic
50% of the rural population were osteopenic and 15% were osteoporotic
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Table 5
EDUCATIONAL STATUS
Level of Education Perimenopausal Menopausal Total
No Formal 
Education
50 62 112
Primary 43 38 81
Secondary 5 12 17
Total 98 112 210
53 % of the study population had no formal education, 39 % had primary education and 8 
% had secondary education.
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Table 6
BODY MASS INDEX
Body Mass Index Normal Osteopenia Osteoporosis Total
<25 33 14 13 60
≥25 83 56 11 150
Total 116 70 24 210
29% of the study group had BMI of less than 25 and 71% of the study group had BMI of ≥ 
25
In the study population with the BMI <25, 23% had osteopenia and 22% osteoporosis.
In the study population with BMI ≥25, 37% had osteopenia, 7% had osteoporosis
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Table 7
HISTORY OF MENOPAUSE
Menopause Normal Osteopenia Osteoporosis Total
NO 69 21 8 98
YES 47 49 16 112
Total 116 70 24 210
46.6% of the study group were perimenopausal and 53.4 % were post-menopausal.
In post-menopausal women 14.2% had osteoporosis and 43.75% had osteopenia
In  the  perimenopausal  women,  nearly  70%  had  a  normal  study  and  only  8%  had 
osteoporosis
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Table 8
SURGICAL MENOPAUSE
Surgical 
Menopause
Normal Osteopenia Osteoporosis Total
Yes 6 13 5 24
24 women in the study group had undergone surgical menopause. The mean age of this 
group was 48.83 years.
The mean age of the study group with natural menopause was 59.76%
 54% of the women who had undergone surgical menopause had osteopenia and 21% had 
osteoporosis.
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Table 9
FAMILY HISTORY OF FRACTURE
Fracture
Normal Osteopenia
Osteoporosi
s
Total
YES 7 13 16 36
NO 109 57 8 174
Total 116 70 24 210
In  the  study  population,  18%  had  a  family  history  of  fracture  of  whom  44%  has 
osteoporosis and 36% has osteopenia
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Table 10
PHYSICAL EXERCISE
Physical 
Exercise Normal Osteopenia Osteoporosis
Total
Yes 49 15 0 64
NO 67 55 24 146
Total 116 70 24 210
69.5% of  the  study population did  not  have physical  exercise  and 30.5% had regular 
physical exercise. Of the study population who did not have regular physical exercise, 
16% had osteoporosis and 38% had osteopenia.
Physical Exercise was associated with the lower incidence of osteoporosis
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RISK FACTOR ANALYSIS - ACTIVE PHYSICAL 
EXERCISE
Normal
77%
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23%
Osteoporosis
0%
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RISK FACTOR ANALYSIS - LACK OF PHYSICAL 
EXERCISE
Osteopenia
38%
Osteoporosis
16%
Normal
46%
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Table 11
HIGH CAFFEINE INTAKE
High Caffeine 
intake
Normal Osteopenia Osteoporosis Total
NO 77 47 6 130
YES 39 23 18 80
Total 116 70 24 210
38%  of  the  study  group  has  a  high  caffeine  intake  of  whom  23%  had  osteoporosis 
compared to 5% osteoporosis in a group who did not have high caffeine intake
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Table 12
LOW CALCIUM INTAKE
Low Calcium Normal Osteopenia Osteoporosis Total
NO 90 45 11 146
YES 26 25 13 64
Total 116 70 24 210
30% of the study population had a low calcium intake of whom 39% had osteopenia and 
20% had osteoporosis
70% of the study population had a normal calcium intake of whom 62% had a normal 
bone density
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Table 13
Z SCORE
Age Group 1 Group 2 Total
41-45 60 4 64
46-50 26 16 42
51-55 16 20 36
56-60 17 11 28
>60 40 0 40
Total 159 51 210
Of the total study population, 76% had a normal bone density when compared to the mean 
BMD for persons of the same age and 24 % had a low bone density when compared to the 
mean BMD for the persons of the same age
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Table 14
ASSOCIATED CO-MORBIDITY
Diseases Group 1 Group 2 Total
Diabetes 27 8 35
Heart Disease 0 4 4
Hypertension 20 0 20
Total 47 12 59
In the study population, the incidence of diabetes melitus in the study population was 59% 
that of systemic hypertension was 34% and ischaemic heart disease was 7%. 
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DISCUSSION
The  reference  study  was  conducted  at  department  of  obstetrics  and 
gynecology,  Ruparel  Medical  Centre,  Worli,  Mumbai.  206  perimenopausal  and 
menopausal  women  had  bone  density  measurement  using  calcaneal  ultrasound  after 
obtaining detailed written consent.
The  present  study was  conducted  at  Kilpauk Medical  College,  Chennai. 
Bone density was measured using Achilles Lunar Calcaneal Ultrasound
AGE: In the reference study, perimenopausal women and menopausal women of 
age 45 and above were included. The average age of perimenopausal women age was 45 
years and that of menopausal women was of 58.5 years.
In the present study, average age of perimenopausal women was 47.7 years 
and the average age of menopausal women was 57 years. In the present study 34.4% had 
undergone  surgical  menopause  and  in  the  reference  study  11.42%  had  surgical 
menopause. 
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12% in the reference study were nulliparous and in the present study 9.5% 
were nulliparous.
In the reference study, age presented a negative association with BMD with 
the P value of 0.064 and in the present study, age had a negative association with BMD 
with a P value of 0.00001 which is statistically significant
A similar negative association of age with BMD was observed in a study by 
the Slenenda et al in1990, Elliot et al in1993 and Ballard et al in1998
BODY MASS INDEX: The mean BMI in the reference study was 23.5 and in 
the mean BMI in the present study is 27.8. 
A lower BMI ( < 25) was associated with T score of less than -1 with a P 
value  of  0.0011  in  the  reference  study and  in  the  present  study a  BMI  of  <  25  was 
associated  with  the  T  Score  of  less  than  -1  with  a  P  value  of  0.006021  which  was 
statistically significant.
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A positive co-relation between low BMI and decreased bone density was 
observed in the study by Van Hemert et al in 1990, Wolinnsky and Fitzerald in 1994, 
Johnell et al in 1995.
PHYSICAL EXERCISE: Lack of physical exercise was associated with 
a lower bone density with a P value of 0.0033 in the reference study.
In the present study lack of physical exercise was associated with a lower 
bone density with a P value of 0.00003.
In the study by Elliot in the year 1993, Goemaere in 1999, Johnell in 1995 a 
similar statistically significant association between lack of physical exercise and low bone 
density was observed.
HIGH CAFFEINE INTAKE: High  Caffeine  intake  was  associated  with 
lower bone density with a P value of 0.006 in the reference study and in the present study 
high caffeine intake was associated with low bone density with the P value of 0.0003.
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Higher caffeine intake was associated with lower bone density in studies by 
Slemenda et al in 1990, Goemaere et al in 1999, Johnell et al in 1995.
LOW CALCIUM INTAKE: In the study population with a calcium intake 
of less than 800 mg per day, a higher incidence of low bone density was noted in the 
reference study with a P value of 0.0086. A similar low bone density in population with 
low calcium intake was observed in studies by Goemaere et al in 1999 and selemenda et 
al. 
In the present study a low calcium intake was associated with lower bone 
density with a P value of 0.0044
FAMILY HISTORY OF FRACTURE: Family history of fracture was 
not included in the questionnaire in the reference study. 
In the present study, family history of fracture was associated with lower 
bone density with a P value of 0.00001. A similar association was noted in the studies by 
Elliot in 1993, Lydick in 1998, Goemaere in 1999 and Kleerekoper in 1989.
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ASSOCIATED CO-MORBIDITY: In the reference study, 11% had 
diabetes, 17% had systemic hypertension and 3% had ischaemic heart disease.
In  the  present  study  59%  had  diabetes  melitus,  34%  had  systemic 
hypertension and 7% ischaemic heart diesease.
INCIDENCE OF OSTEOPENIA AND OSTEOPOROSIS IN 
PERIMENOPAUSAL WOMEN
In the reference study, 30% of the perimenopausal women had osteopenia 
(T Score < -1 to -2.5) and 5% had osteoporosis.
In the present study, 21% had osteopenia and 8% had osteoporosis. 
INCIDENCE OF OSTEOPENIA AND OSTEOPOROSIS IN MENOPAUSAL 
WOMEN
In the reference study, 38.4% of the menopausal women had osteopenia (T 
Score < -1 to -2.5) and 48% had osteoporosis.
In the present study, 44% had osteopenia and 14% had osteoporosis. 
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Z SCORE: The  Z  score  which  compares  one  person’s  BMD  in  standard 
deviations with the mean BMD for persons of the same age and gender rather than with a 
young adult normal group. The z score of greater than -1 was noted in 76 % of the study 
population and 24% had a Z score of ≤ -1.  
This study shows nearly two thirds of the study population had normal bone 
density when compared to the population of same age and gender. 
Z score was not studied in the reference study.
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SUMMARY
• 98 perimenopausal  women and 112 post  menopausal  women from age group 40 
years and above were selected according to the inclusion and exclusion criteria.
• The mean age of the study group was 52.72 years
• 11.42 % of the study population had undergone surgical menopause
• The mean age of the women who had undergone surgical  menopause was 48.83 
years and 59.76 years was the mean age of the study group who had experienced 
natural menopause.
• 81% of the population were from urban area and 53% of the study population had no 
formal education
• 29% of the study group had a BMI less than 25
• Bone  density  was  measured  in  the  right  heel  using  Achilles  Lunar  Calcaneal 
Ultrasound
• The results were interpreted using T-Score and Z-Score criteria for osteopenia and 
osteoporosis
• A body mass index less than 25, family history of fracture, lack of physical exercise, 
high caffeine intake, low calcium intake were associated with osteoporosis and the 
association was found to be statistically significant for each of the above risk factors
• In the perimenopausal women, 21% had osteopenia and 8% had osteoporosis.
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• In the menopausal women,  44% had osteopenia and 14% had osteoporosis
• In the women who had undergone surgical menopause, 54% had osteopenia and 21% 
had osteoporosis.
• 76% of the study group had a normal bone density when compared to mean bone 
density for persons of the same age and 24% had low bone density.
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CONCLUSION
By its nature osteoporosis progresses silently for years without symptoms 
and is therefore a “silent bone thinning disease” without symptoms. The bone is a mineral 
bank  whose  assets  must  be  built  up,  maintained  and  protected.  The  development  of 
lifelong habits of nutrition and weight  bearing exercise,  avoidance of risk factors  that 
promote  the  development  of  osteoporosis  and  timely  management  to  decrease  the 
withdrawal of bone from the bank are necessary to protect these vital assets from the silent 
thief osteoporosis.
 Bone  densitometry  has  well  established  usefulness  in  assessing 
osteoporosis and fracture risk. Although DEXA (Dual Energy X-Ray Absorptiometry) is 
the  Gold  Standard  test  in  the  diagonosis  of  osteoporosis,  DEXA  has  the  following 
disadvantages.
• The equipment is costly and is not portable
• The procedure involves radiation exposure
• It is available only in specialist institution
• It requires time and operator skill
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The cost of DEXA precludes its use for screening purposes, especially in 
developing countries like India where maternal and child health programs receive major 
chunks in funds from health budget and financial support to programs for geriatric health 
problems may be negligible.
This is a small clinical trial to study the bone mass of perimenopausal and 
menopausal women and to diagnose the level of osteoporosis in the community. Calcaneal 
ultrasound  is  newer  evolving  promising  tool  to  assess  bone  density  as  it  is  precise, 
noninvasive, quick and cost effective. 
Advantages of QUS
• Equipment cost is substantially low.
• Equipment is generally portable
• There is no radiation exposure
• The device requires much less space.
• The time required for testing is only few minutes
• Does not need operator skill
• QUS is relatively cheap
• The technique is easy as the peripheral skeleton is studied
• QUS has high sensitivity
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• QUS expresses qualitative features of bone
Every  postmenopausal  women  and  all  perimenopausal  women  with 
increased risk factor should therefore undergo bone density testing so that they can be 
saved from the crippling disease. In developing country like India where the burden of 
osteoporosis in immense and is predicted to increase in the near future, QUS can be used 
as a cost-effective screening tool for osteoporosis. Almost all patients with BMD in the 
osteoporotic range on densitometry and many of those with value in osteopenic range 
should be considered for HRT based on individual  risk factor  calcium and vitamin  D 
supplementation 
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PROFORMA
Name :
Age :
Socio-Economic Class :
Occupation :
Educational Status : No Formal Education / Primary / Secondary
Place of Residence : Urban / Rural
Height :
Weight :
Body Mass Index :
Menstrual History :
Menstruating Post-Menopausal
Regular Irregular Natural Surgical 
(Hysterectomy 
with  both  ovaries 
removed)
History of : Diabetes/Hypertension/Ischaemic Heart Disease:
Family H/O of Fracture :
Dietary Habits : Total Calories
Total Calcium Intake
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Total Caffeine Intake
H/O Calcium Supplementation:
Dose and Duration
Physical Activity : Nil
Active Physical Exercise: Walking
Cycling
Swimming
H/O Hormone Replacement Therapy
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MASTER CHART
Name Age Occupation Weight (kg)
Height
 (cm) BMI
Usha 41 Tailor 67 153 28.62
Usha 41 Optometrist 67 153 28.62
Vijayalakshmi 41 housewife 67 153 28.62
Lathadevi 41 housemaid 67 153 28.62
Selvi 41 Housewife 60 154 25.3
Selvi 41 Housewife 60 154 25.3
Amirthammal 41 Housewife 60 154 25.3
Kuppamal 41 Housewife 60 154 25.3
Parvathi 41 Housewife 73 150 32.44
Paravathammal 41 Housewife 73 150 32.44
Rajini 41 Housewife 73 150 32.44
Muthamizh 41 Housewife 73 150 32.44
Anitha B 42 Housewife 55 154 23.19
Ulagammal 42 Housewife 55 154 23.19
Thenmozhi 42 Housewife 55 154 23.19
Manikkavalli 42 Housewife 55 154 23.19
Ananthi 42 Housewife 68 152 29.43
Mariyammal 42 Housewife 68 152 29.43
Roja 42 Housewife 68 152 29.43
Irudayam 42 Housewife 68 152 29.43
Ezhilarasi 43 Housewife 60 153 25.63
Ezhilarasi 43 Housewife 60 153 25.63
Suryakala 43 Housewife 60 153 25.63
Bagyam 43 Housewife 60 153 25.63
Haripriya 43 Housewife 74 144 35.69
Kalai 43 Housewife 74 144 35.69
Muthamizhselvi 43 Housewife 74 144 35.69
Malathi Priya 43 Housewife 74 144 35.69
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Menstrual History No. Of Children
Medical Disorders
Diabetes Heart Disease Hypertension
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Hysterectomy Done 2 NO NO NO
Hysterectomy Done 2 NO NO NO
Hysterectomy Done 2 NO NO NO
Hysterectomy Done 2 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
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Risk Factors
Sedentary 
Lifestyle
Nulliparit
y
High 
Caffeine 
Intake
Low 
Calcium 
Intake
Steroid
s
Family 
H/O 
Fracture
Post-
Menopausal 
Status
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
YES NIL YES NO NO NO NO
YES NIL YES NO NO NO NO
YES NIL YES NO NO NO NO
YES NIL YES NO NO NO NO
NIL NIL NO YES NO NO NO
NIL NIL NO YES NO NO NO
NIL NIL NO YES NO NO NO
NIL NIL NO YES NO NO NO
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
97
HRT T-Score Z-Score Stiffness Index
NO -1.2 -1.2 81
NO -1.2 -1.2 81
NO -1.2 -1.2 81
NO -1.2 -1.2 81
NO 0.2 0.3 103
NO 0.2 0.3 103
NO 0.2 0.3 103
NO 0.2 0.3 103
NO 0.7 0.8 111
NO 0.7 0.8 111
NO 0.7 0.8 111
NO 0.7 0.8 111
NO -1 -0.9 85
NO -1 -0.9 85
NO -1 -0.9 85
NO -1 -0.9 85
NO -0.2 0 97
NO -0.2 0 97
NO -0.2 0 97
NO -0.2 0 97
NO -0.9 -0.8 85
NO -0.9 -0.8 85
NO -0.9 -0.8 85
NO -0.9 -0.8 85
NO 0.3 0.3 104
NO 0.3 0.3 104
NO 0.3 0.3 104
NO 0.3 0.3 104
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Name Age Occupation Weight (kg)
Height
 (cm) BMI
Muniammal 43 Housewife 38 140 19.39
Muniammal 43 Housewife 38 140 19.39
Logammal 43 Housewife 38 140 19.39
Senthamizselvi 43 Housewife 38 140 19.39
Selvi 43 Housewife 80 164 29.74
Selvi 43 Housewife 80 164 29.74
Sulokshana 43 Housewife 80 164 29.74
Latha 43 Housewife 80 164 29.74
Uma 43 Labourer 64 150 28.44
Uma Rani 43 Labourer 64 150 28.44
Mumthaz Begam 43 Labourer 64 150 28.44
Mangayarkarasi 43 Labourer 64 150 28.44
Visalakshi 44 Housewife 66 157 26.78
Visalakshi 44 Housewife 66 157 26.78
Manikkadevi 44 Housewife 66 157 26.78
Ragini 44 Housewife 66 157 26.78
Shantha 44 Housewife 72 164 26.77
Mohana 44 Housewife 72 164 26.77
Kanimozhi 44 Housewife 72 164 26.77
Kaveri 44 Housewife 72 164 26.77
Vasanthi 45 Warden 49 160 19.14
Vasantha 45 Housewife 49 160 19.14
Thamizarasi 45 housemaid 49 160 19.14
Poongodi 45 accountant 49 160 19.14
Ramya 45 Housewife 69 155 28.72
Easwari 45 Housewife 69 155 28.72
Nargeez Banu 45 Housewife 69 155 28.72
Sarasu 45 Housewife 69 155 28.72
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Menstrual History No. Of Children
Medical Disorders
Diabetes Heart Disease Hypertension
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Hysterectomy Done 3 NO NO NO
Hysterectomy Done 3 NO NO NO
Hysterectomy Done 3 NO NO NO
Hysterectomy Done 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 4 NO NO NO
Regular 4 NO NO NO
Regular 4 NO NO NO
Regular 4 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
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Risk Factors
Sedentary 
Lifestyle
Nulliparit
y
High 
Caffeine 
Intake
Low 
Calcium 
Intake
Steroid
s
Family 
H/O 
Fracture
Post-
Menopausal 
Status
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
YES NIL YES YES NO NO NO
YES NIL YES YES NO NO NO
YES NIL YES YES NO NO NO
YES NIL YES YES NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
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HRT T-Score Z-Score Stiffness Index
NO 0.4 1 105
NO 0.4 1 105
NO 0.4 1 105
NO 0.4 1 105
NO 0.6 0.6 101
NO 0.6 0.6 101
NO 0.6 0.6 101
NO 0.6 0.6 101
NO 0.7 0.6 89
NO 0.7 0.6 89
NO 0.7 0.6 89
NO 0.7 0.6 89
NO -0.6 -0.5 91
NO -0.6 -0.5 91
NO -0.6 -0.5 91
NO -0.6 -0.5 91
NO 0.8 0.9 113
NO 0.8 0.9 113
NO 0.8 0.9 113
NO 0.8 0.9 113
NO -0.5 -0.5 93
NO -0.5 -0.5 93
NO -0.5 -0.5 93
NO -0.5 -0.5 93
NO -0.3 -0.1 95
NO -0.3 -0.1 95
NO -0.3 -0.1 95
NO -0.3 -0.1 95
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Name Age Occupation Weight (kg)
Height
 (cm) BMI
Rajalakshmi 45 Housewife 85 180 26.23
Rajalakshmi 45 Housewife 85 180 26.23
Lakshmi 45 Housewife 85 180 26.23
Dhanam 45 Housewife 85 180 26.23
Parimala 45 Housewife 59 149 26.58
Yogeswari 45 Housewife 59 149 26.58
Ezhilarasi 45 Housewife 59 149 26.58
Priya 45 Housewife 59 149 26.58
Shanthi 46 Labourer 46 140 23.47
Aarthy Gopal 46 Labourer 46 140 23.47
Gayathri 46 Labourer 46 140 23.47
Abirami 46 Labourer 46 140 23.47
Maliga 46 Housewife 63 146 29.56
Irudaya Mary 46 Housewife 63 146 29.56
Ragini 46 Housewife 60 153 25.63
Jevitha Rani 46 Housewife 60 153 25.63
Sundari 46 Housewife 60 153 25.63
Balanagammal 46 Housewife 60 153 25.63
Mumtaz 47 Accountant 75 169 26.26
Mumtaz 47 Accounts Executive 75 169 26.26
Shailabanu 47 housewife 75 169 26.26
Geeta 47 office assistant 75 169 26.26
Mala 47 Housewife 69 150 30.67
Malarvizhi 47 Housewife 69 150 30.67
Punitha 47 Housewife 69 150 30.67
Punithavalli 47 Housewife 69 150 30.67
Bakya 47 Housemaid 75 150 33.33
Emily Margarat 47 housewife 75 150 33.33
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Menstrual History No. Of Children
Medical Disorders
Diabetes Heart Disease Hypertension
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Regular 1 NO NO NO
Hysterectomy Done 2 NO NO YES
Hysterectomy Done 2 NO NO YES
Hysterectomy Done 2 NO NO YES
Hysterectomy Done 2 NO NO YES
Menopause nil YES NO YES
Menopause nil YES NO YES
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Risk Factors
Sedentary 
Lifestyle
Nulliparit
y
High 
Caffeine 
Intake
Low 
Calcium 
Intake
Steroid
s
Family 
H/O 
Fracture
Post-
Menopausal 
Status
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
YES NIL NO NO YES NO NO
YES NIL NO NO YES NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
NIL NIL NO NO NO NO NO
YES NIL NO YES NO NO NO
YES NIL NO YES NO NO NO
YES NIL NO YES NO NO NO
YES NIL NO YES NO NO NO
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
NIL YES NO NO NO NO YES
NIL YES NO NO NO NO YES
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HRT T-Score Z-Score Stiffness Index
NO 0.7 1 112
NO 0.7 1 112
NO 0.7 1 112
NO 0.7 1 112
NO 2.3 3.2 130
NO 2.3 3.2 130
NO 2.3 3.2 130
NO 2.3 3.2 130
NO -2.1 -1.9 66
NO -2.1 -1.9 66
NO -2.1 -1.9 66
NO -2.1 -1.9 66
NO -0.8 -0.5  
NO -0.8 -0.5  
NO -0.3 -0.1 95
NO -0.3 -0.1 95
NO -0.3 -0.1 95
NO -0.3 -0.1 95
NO -1.3 -1.2 79
NO -1.3 -1.2 79
NO -1.3 -1.2 79
NO -1.3 -1.2 79
NO -1.1 0.7 83
NO -1.1 0.7 83
NO -1.1 0.7 83
NO -1.1 0.7 83
NO 0.1 0.5 102
NO 0.1 0.5 102
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Name Age Occupation Weight (kg)
Height
 (cm) BMI
Vedavalli 47 clerk 75 150 33.33
Arasi 47 housewife 75 150 33.33
Geeta 48 Housewife 49 143 23.96
Geeta Mary 48 Housewife 49 143 23.96
Nayagi 48 Housewife 49 143 23.96
Malakodi 48 Housewife 49 143 23.96
Parameswari 48 Housewife 65 147 30.08
Parameswari 48 Housewife 65 147 30.08
Kamala Mary 48 Housewife 65 147 30.08
Muthulakshmi 48 Housewife 65 147 30.08
Suguna 49 Housewife 64 160 25
Suguna 49 Housewife 64 160 25
Dhanabagyam 49 Housewife 64 160 25
Nirmala 49 Housewife 64 160 25
Viajakumari 50 Housewife 50 130 29.59
Nagarani 50 Housewife 50 130 29.59
Kokila 50 Housewife 50 130 29.59
Saraswathi 50 Housewife 50 130 29.59
Jyothi 50 Housewife 67 160 26.17
Jyothi 50 Housewife 67 160 26.17
Mangala Arasi 50 Housewife 67 160 26.17
Jagathammal 50 Housewife 67 160 26.17
Indrani S 51 Clerk 65 140 33.16
Gomathi 51
Office 
Superdintendent 65 140 33.16
Sornam 51 housewife 65 140 33.16
Devipriya 51 clerk 65 140 33.16
Jyothi 51 Housewife 73 154 30.78
Lakshmipriya 51 Housewife 73 154 30.78
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Menstrual History No. Of Children
Medical Disorders
Diabetes Heart Disease Hypertension
Menopause nil YES NO YES
Menopause nil YES NO YES
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Regular 3 NO NO NO
Menopause 3 NO NO NO
Menopause 3 NO NO NO
Menopause 3 NO NO NO
Menopause 3 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause n NO NO NO
Menopause n NO NO NO
Menopause n NO NO NO
Menopause n NO NO NO
Irregular 2 NO NO NO
Irregular 2 NO NO NO
Irregular 2 NO NO NO
Irregular 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
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Risk Factors
Sedentary 
Lifestyle
Nulliparit
y
High 
Caffeine 
Intake
Low 
Calcium 
Intake
Steroid
s
Family 
H/O 
Fracture
Post-
Menopausal 
Status
NIL YES NO NO NO NO YES
NIL YES NO NO NO NO YES
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES YES NO YES YES YES YES
YES YES NO YES YES YES YES
YES YES NO YES YES YES YES
YES YES NO YES YES YES YES
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
NIL NIL NO YES NO NO NO
NIL NIL NO YES NO NO NO
NIL NIL NO YES NO NO NO
NIL NIL NO YES NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
109
HRT T-Score Z-Score Stiffness Index
NO 0.1 0.5 102
NO 0.1 0.5 102
NO -0.5 -0.1 92
NO -0.5 -0.1 92
NO -0.5 -0.1 92
NO -0.5 -0.1 92
NO -0.2 0.1 96
NO -0.2 0.1 96
NO -0.2 0.1 96
NO -0.2 0.1 96
NO -1 -0.6 84
NO -1 -0.6 84
NO -1 -0.6 84
NO -1 -0.6 84
NO -1.8 -1.3 71
NO -1.8 -1.3 71
NO -1.8 -1.3 71
NO -1.8 -1.3 71
NO -1.7 -1.7 75
NO -1.7 -1.7 75
NO -1.7 -1.7 75
NO -1.7 -1.7 75
NO -1.9 -1.4 69
NO -1.9 -1.4 69
NO -1.9 -1.4 69
NO -1.9 -1.4 69
NO -1.4 -1.4 78
NO -1.4 -1.4 78
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Name Age Occupation Weight (kg)
Height
 (cm) BMI
Joythishwari 51 Housewife 73 154 30.78
Rajameenakshi 51 Housewife 73 154 30.78
Usha 51 Housewife 60 148 27.39
Sudha Rani 51 Housewife 60 148 27.39
Kavitha 51 Housewife 60 148 27.39
Naramada 51 Housewife 60 148 27.39
Majula 52 Housewife 55 154 23.19
Malarvizhi 52 Housewife 55 154 23.19
Anantavalli 52 Housewife 55 154 23.19
Senthamarai 52 Housewife 55 154 23.19
Indrani P 54 Housewife 54 150 24
Sarathambal 54 Housewife 54 150 24
Padma 54 Housewife 54 150 24
Rasathi 54 Housewife 54 150 24
Rani 54 Housewife 63 148 28.76
Kausalya 54 Housewife 80 150 35.56
Kausalya 54 Housewife 80 150 35.56
Nagammal 54 Housewife 63 148 28.76
Theivanayagi 54 Housewife 80 150 35.56
Kamala 54 Housewife 80 150 35.56
Anjala 54 Housewife 63 148 28.76
Nagammal 54 Housewife 63 148 28.76
Indrani 55 Housewife 60 160 23.44
Indra 55 Housewife 60 160 23.44
Valli 55 Housewife 60 160 23.44
Ganga 55 Housewife 60 160 23.44
Shantha 55 Housewife 80 150 35.56
Jayalakshmi 55 Housewife 80 150 35.56
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Menstrual History No. Of Children
Medical Disorders
Diabetes Heart Disease Hypertension
Regular 2 NO NO NO
Regular 2 NO NO NO
Hysterectomy Done 2 YES NO YES
Hysterectomy Done 2 YES NO YES
Hysterectomy Done 2 YES NO YES
Hysterectomy Done 2 YES NO YES
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Regular 2 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Hysterectomy Done 2 YES NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Hysterectomy Done 2 YES NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Hysterectomy Done 2 YES NO NO
Hysterectomy Done 2 YES NO NO
Hysterectomy Done 7 YES YES NO
Hysterectomy Done 7 YES YES NO
Hysterectomy Done 7 YES YES NO
Hysterectomy Done 7 YES YES NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
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Risk Factors
Sedentary 
Lifestyle
Nulliparit
y
High 
Caffeine 
Intake
Low 
Calcium 
Intake
Steroid
s
Family 
H/O 
Fracture
Post-
Menopausal 
Status
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL YES NO NO YES YES
YES NIL YES NO NO YES YES
YES NIL YES NO NO YES YES
YES NIL YES NO NO YES YES
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
YES NIL YES YES NO YES YES
YES NIL YES YES NO YES YES
YES NIL YES YES NO YES YES
YES NIL YES YES NO YES YES
YES NIL YES YES NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL YES YES NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
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HRT T-Score Z-Score Stiffness Index
NO -1.4 -1.4 78
NO -1.4 -1.4 78
YES -1.3 -0.7 80
YES -1.3 -0.7 80
YES -1.3 -0.7 80
YES -1.3 -0.7 80
NO -1.7 -1.7 72
NO -1.7 -1.7 72
NO -1.7 -1.7 72
NO -1.7 -1.7 72
NO -2.7 -1.9 82
NO -2.7 -1.9 82
NO -2.7 -1.9 82
NO -2.7 -1.9 82
NO -1.5 -0.7 75
NO -1.5 0.6 76
NO -1.5 0.6 76
NO -1.5 -0.7 75
NO -1.5 0.6 76
NO -1.5 0.6 76
NO -1.5 -0.7 75
NO -1.5 -0.7 75
NO -2.6 -1.6 59
NO -2.6 -1.6 59
NO -2.6 -1.6 59
NO -2.6 -1.6 59
NO 1 1.9 116
NO 1 1.9 116
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Name Age Occupation Weight (kg)
Height
 (cm) BMI
Banu 55 Housewife 80 150 35.56
Parichatham 55 Housewife 80 150 35.56
Kalawathy 58 Housewife 57 148 26.02
Priyadevi 58 Housewife 57 148 26.02
Theivanai 58 Housewife 57 148 26.02
Kasthuri 58 Housewife 57 148 26.02
Saraswathy 59 Housewife 94 148 42.91
Kumudha 59 Housewife 94 148 42.91
Sarasu 59 Housewife 94 148 42.91
Aatchi 59 Housewife 94 148 42.91
Chellamal 60 Housewife 74 140 37.76
Rajam 60 Housewife 55 150 24.44
Stella Mary 60 Housewife 74 140 37.76
Rajalakshmi 60 Housewife 55 150 24.44
Vidya 60 Housewife 55 150 24.44
Manimozhi 60 Housewife 74 140 37.76
Mangalam 60 Housewife 74 140 37.76
Nagalakshmi 60 Housewife 55 150 24.44
Panjalai 60 Housewife 38 145 18.07
Devipriya 60 Housewife 38 145 18.07
Lurdhu Mary 60 Housewife 38 145 18.07
Gajalakshmi 60 Housewife 38 145 18.07
Aarthy 60 Housewife 55 150 24.44
Vishalakshi 60 Housewife 55 150 24.44
Urvasi 60 Housewife 55 150 24.44
Loganayagi 60 Housewife 55 150 24.44
Parvathammal 60 Housewife 59 156 24.24
Suganthammal 60 Housewife 59 156 24.24
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Menstrual History No. Of Children
Medical Disorders
Diabetes Heart Disease Hypertension
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Irregular 2 NO NO NO
Irregular 2 NO NO NO
Irregular 2 NO NO NO
Irregular 2 NO NO NO
Menopause 2 NO NO NO
Menopause 3 YES NO NO
Menopause 2 NO NO NO
Menopause 3 YES NO NO
Menopause 3 YES NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 3 YES NO NO
Menopause nil NO NO NO
Menopause nil NO NO NO
Menopause nil NO NO NO
Menopause nil NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause 2 NO NO NO
Menopause nil YES NO NO
Menopause nil YES NO NO
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Risk Factors
Sedentary 
Lifestyle
Nulliparit
y
High 
Caffeine 
Intake
Low 
Calcium 
Intake
Steroid
s
Family 
H/O 
Fracture
Post-
Menopausal 
Status
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO YES NO
YES NIL YES YES NO YES NO
YES NIL YES YES NO YES NO
YES NIL YES YES NO YES NO
YES NIL YES YES YES YES NO
YES NIL YES NO NO YES YES
YES NIL YES YES YES YES NO
YES NIL YES NO NO YES YES
YES NIL YES NO NO YES YES
YES NIL YES YES YES YES NO
YES NIL YES YES YES YES NO
YES NIL YES NO NO YES YES
YES YES NO NO NO YES YES
YES YES NO NO NO YES YES
YES YES NO NO NO YES YES
YES YES NO NO NO YES YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES YES YES YES NO YES YES
YES YES YES YES NO YES YES
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HRT T-Score Z-Score Stiffness Index
NO 1 1.9 116
NO 1 1.9 116
NO 0.1 0.6 101
NO 0.1 0.6 101
NO 0.1 0.6 101
NO 0.1 0.6 101
NO -3.7 2 40
NO -3.7 -3.7 40
NO -3.7 -3.7 40
NO -3.7 -3.7 40
NO -2.5 -1.1 61
YES -2.5 -1.1 69
NO -2.5 -1.1 61
YES -2.5 -1.1 69
YES -2.5 -1.1 69
NO -2.5 -1.1 61
NO -2.5 -1.1 61
YES -2.5 -1.1 69
NO -2.1 -0.6 73
NO -2.1 -0.6 73
NO -2.1 -0.6 73
NO -2.1 -0.6 73
NO -1 -0.1 87
NO -1 -0.1 87
NO -1 -0.1 87
NO -1 -0.1 87
NO -0.3 1.1 96
NO -0.3 1.1 96
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Name Age Occupation Weight (kg)
Height
 (cm) BMI
Balasundari 60 Housewife 59 156 24.24
Thamiz 60 Housewife 59 156 24.24
Shakunthala 62 Housewife 67 167 24.02
Sublakshmi 62 Housewife 67 167 24.02
Ranjinidevi 62 Housewife 67 167 24.02
Vimala 62 Housewife 67 167 24.02
Narmada 63 Housewife 72 152 31.16
Narmada 63 Housewife 72 152 31.16
Selvarani 63 Housewife 72 152 31.16
Gajalakshmi 63 Housewife 72 152 31.16
Manimegalai 63 Housewife 56 154 23.61
Manimegalai 63 Housewife 56 154 23.61
Ranjini 63 Housewife 56 154 23.61
Thayammal 63 Housewife 56 154 23.61
Suryakantha 65 Housewife 65 147 30.08
Amudha 65 Housewife 65 147 30.08
Rajam 65 Housewife 65 147 30.08
Sumathi 65 Housewife 65 147 30.08
Ramya 66 Housewife 61 154 25.72
Vijita Bai 66 houseMaid 61 154 25.72
Ellamal 66 Labourer 61 154 25.72
Kumudha 66 FlowerVendor 61 154 25.72
Andal 69 Housewife 60 147 27.77
Parimala 69 Housewife 60 147 27.77
Priya Mani 69 Housewife 60 147 27.77
Thangam 69 Housewife 60 147 27.77
Rajeswari 72 Housewife 57 150 25.33
Raja Rajeswari 72 Housewife 57 150 25.33
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Menstrual History No. Of Children
Medical Disorders
Diabetes Heart Disease Hypertension
Menopause nil YES NO NO
Menopause nil YES NO NO
Menopause nil NO NO NO
Menopause nil NO NO NO
Menopause nil NO NO NO
Menopause nil NO NO NO
Menopause 3 NO NO YES
Menopause 3 NO NO YES
Menopause 3 NO NO YES
Menopause 3 NO NO YES
Menopause 4 YES NO NO
Menopause 4 YES NO NO
Menopause 4 YES NO NO
Menopause 4 YES NO NO
Menopause 3 YES NO NO
Menopause 3 YES NO NO
Menopause 3 YES NO NO
Menopause 3 YES NO NO
Menopause 3 NO NO NO
Menopause 3 NO NO NO
Menopause 3 NO NO NO
Menopause 3 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO YES
Menopause 4 NO NO YES
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Risk Factors
Sedentary 
Lifestyle
Nulliparit
y
High 
Caffeine 
Intake
Low 
Calcium 
Intake
Steroid
s
Family 
H/O 
Fracture
Post-
Menopausal 
Status
YES YES YES YES NO YES YES
YES YES YES YES NO YES YES
YES YES YES YES NO NO YES
YES YES YES YES NO NO YES
YES YES YES YES NO NO YES
YES YES YES YES NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL YES NO NO NO NO
YES NIL YES NO NO NO NO
YES NIL YES NO NO NO NO
YES NIL YES NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
YES NIL NO NO NO NO NO
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
NIL NIL NO NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES NO NO NO YES
YES NIL YES YES NO YES YES
YES NIL YES YES NO YES YES
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HRT T-Score Z-Score Stiffness Index
NO -0.3 1.1 96
NO -0.3 1.1 96
NO -0.7 0.8 89
NO -0.7 0.8 89
NO -0.7 0.8 89
NO -0.7 0.8 89
NO -2 0 92
NO -2 0 92
NO -2 0 92
NO -2 0 92
NO -0.6 0.9 90
NO -0.6 0.9 90
NO -0.6 0.9 90
NO -0.6 0.9 90
NO -1.1 0.5 82
NO -1.1 0.5 82
NO -1.1 0.5 82
NO -1.1 0.5 82
NO -0.4 0.9 93
NO -0.4 0.9 93
NO -0.4 0.9 93
NO -0.4 0.9 93
NO -0.3 1.5 96
NO -0.3 1.5 96
NO -0.3 1.5 96
NO -0.3 1.5 96
NO 1.5 3.3 124
NO 1.5 3.3 124
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Name Age Occupation Weight (kg)
Height
 (cm) BMI
Valliyammal 72 Housewife 57 150 25.33
Ganga 72 Housewife 57 150 25.33
Gnanmbal 73 Housewife 77 145 36.62
Gnanmbal 73 Housewife 77 145 36.62
Veerammal 73 Housewife 77 145 36.62
Ganthimathi 73 Housewife 77 145 36.62
Ponmozhi 75 Housewife 56 144 27.01
Kayalmozhi 75 Housewife 56 144 27.01
Saradha 75 Housewife 56 144 27.01
Meenakshi 75 Housewife 56 144 27.01
Chandrabai 75 Housewife 63 143 30.81
Thamizselvi 75 Housewife 63 143 30.81
Girija 75 Housewife 63 143 30.81
Dhanam 75 Housewife 63 143 30.81
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Menstrual History No. Of Children
Medical Disorders
Diabetes Heart Disease Hypertension
Menopause 4 NO NO YES
Menopause 4 NO NO YES
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 NO NO NO
Menopause 4 YES NO NO
Menopause 4 YES NO NO
Menopause 4 YES NO NO
Menopause 4 YES NO NO
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Risk Factors
Sedentary 
Lifestyle
Nulliparit
y
High 
Caffeine 
Intake
Low 
Calcium 
Intake
Steroid
s
Family 
H/O 
Fracture
Post-
Menopausal 
Status
YES NIL YES YES NO YES YES
YES NIL YES YES NO YES YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL NO NO NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
YES NIL YES YES NO NO YES
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HRT T-Score Z-Score Stiffness Index
NO 1.5 3.3 124
NO 1.5 3.3 124
NO -2.4 -0.5 62
NO -2.4 -0.5 62
NO -2.4 -0.5 62
NO -2.4 -0.5 62
NO -2.2 -0.3 65
NO -2.2 -0.3 65
NO -2.2 -0.3 65
NO -2.2 -0.3 65
NO -2.1 -0.2 67
NO -2.1 -0.2 67
NO -2.1 -0.2 67
NO -2.1 -0.2 67
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